FDA Increases OTC Monograph User Fees by 19 Percent for Fiscal 2022 Post author:PacConAdmin Post published:March 14, 2022 Post category:Drug Industry Daily The FDA has released its over-the-counter (OTC) monograph drug user fees for fiscal 2022. Source: Drug Industry Daily You Might Also Like Tax Court: Mylan Must Deliver Licensing Agreement Docs to the IRS February 27, 2017 Pew Finds State Oversight of Compounders Improved, But Some Lack Inspection Resources February 27, 2018 FDA Novel Drug Approvals Spiked Last Year January 2, 2018
Pew Finds State Oversight of Compounders Improved, But Some Lack Inspection Resources February 27, 2018